• Received first approval in China from our India facility
  • Started Phase III clinical trials for PCV
  • Acquired 9 OTC brands
  • Filed the first biosimilar with the European Medical Agency(EMA)

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. I AcceptCookie policy